Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which includes a pipeline of novel biologic therapeutic candidates, developed using proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize multivalent formats where the precise valency can be optimized in a target-centric way to mediate what is believed to be the most appropriate agonist function. The company was founded by Brendan P. Eckelman on January 8, 2024 and is headquartered in La Jolla, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
161
Frequently Asked Questions
What is Market Cap of Inhibrx Biosciences Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Inhibrx Biosciences Inc. market cap is $408.2M.
What is the 52-week high for Inhibrx Biosciences Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Inhibrx Biosciences Inc. 52 week high is $28.73 as of September 06, 2025.
What is the 52-week low for Inhibrx Biosciences Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Inhibrx Biosciences Inc. 52 week low is $10.81 as of September 06, 2025.
What is Inhibrx Biosciences Inc. stock price today?
Inhibrx Biosciences Inc. stock price today is $28.18.
What was Inhibrx Biosciences Inc. stock price yesterday?
Inhibrx Biosciences Inc. stock price yesterday was $27.72.
What is the PE ratio of Inhibrx Biosciences Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Inhibrx Biosciences Inc.’s P/E ratio is -2.56.
What is the Price-to-Book ratio of Inhibrx Biosciences Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Inhibrx Biosciences Inc. P/B ratio is 5.9501.
What is the 50-day moving average of Inhibrx Biosciences Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Inhibrx Biosciences Inc. 50-day moving average is $22.52.
How many employess does Inhibrx Biosciences Inc. has?
